The Latest
-
Orthocell shares soar 22% on landmark US breakthrough
-
This ASX biotech stock just jumped again as its lead drug trial moves ahead
-
Why is this $25 billion ASX mining stock charging higher today?
-
Are Qantas shares still a buy after its latest market update?